Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand

ST. GALLEN, Switzerland & SAN DIEGO, Calif. — (BUSINESS WIRE) — Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/new…